GM 109

Known as: GM-109 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2010
02419952010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The pharmacological properties of mitemcinal (GM-611), the first acid-resistant non-peptide motilin agonist, were investigated in… (More)
Is this relevant?
2007
2007
Motilin and motilin receptors have been found in most regions of the brain, including the amygdala, one of the most important… (More)
Is this relevant?
2006
2006
The prokinetic effects of mitemcinal, an orally active motilin receptor agonist, on the lower gastrointestinal tracts were… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2003
2003
The structural relationship between the motilin and the growth hormone secretagogue receptor (GHS-R), and between their… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2001
2001
Motilin has excitatory effects on the colon of the rabbit and the dog, but little is known of its effect on the human colon. The… (More)
Is this relevant?
2000
2000
Motilin receptors were classically recognized in the gastroduodenal area, where they help to regulate interdigestive motility… (More)
Is this relevant?
1998
1998
There have been few reports on the effects of the brain-gut peptide motilin on the central nervous system (CNS). We administered… (More)
Is this relevant?
1998
1998
The effect of motilin on food intake was investigated in nonfood-deprived mice. A significant increase in food intake was… (More)
Is this relevant?
1997
1997
In man, rabbit and cat, the effects of motilin and motilides are neurally mediated in vivo, whereas in vitro binding and… (More)
Is this relevant?
1995
1995
The pharmacological properties of the cyclic peptide Phe-cyclo[Lys-Tyr(3-tBu)-beta Ala-].trifluoroacetate (GM-109), a selective… (More)
Is this relevant?